NextPlat Reports Consolidated Third Quarter 2023 Results with Increased Revenues of 15.3 Million, Margin - Benzinga
| OPK Stock | 574.20 21.80 3.66% |
About 61% of Opko Health's investor base is looking to short. The analysis of current outlook of investing in Opko Health suggests that many traders are alarmed regarding Opko Health's prospects. The current market sentiment, together with Opko Health's historical and current headlines, can help investors time the market. In addition, many technical investors use Opko Health stock news signals to limit their universe of possible portfolio assets.
Opko |
NextPlat Reports Consolidated Third Quarter 2023 Results with Increased Revenues of 15.3 Million, Margin Benzinga
Read at news.google.com
 |
Opko Health Fundamental Analysis
We analyze Opko Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opko Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opko Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Opko Health is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Opko Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Opko Health stock to make a market-neutral strategy. Peer analysis of Opko Health could also be used in its relative valuation, which is a method of valuing Opko Health by comparing valuation metrics with similar companies.
Peers
Opko Health Related Equities
| ESLT | Elbit Systems | 3.87 | ||||
| TSEM | Tower Semiconductor | 2.87 | ||||
| NICE | Nice | 0.86 | ||||
| KMDA | Kamada | 1.40 | ||||
| TEVA | Teva Pharmaceutical | 4.20 |
Complementary Tools for Opko Stock analysis
When running Opko Health's price analysis, check to measure Opko Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opko Health is operating at the current time. Most of Opko Health's value examination focuses on studying past and present price action to predict the probability of Opko Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opko Health's price. Additionally, you may evaluate how the addition of Opko Health to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |